Literature DB >> 2039036

Conjunctival necrosis after administration of topical fortified aminoglycosides.

C R Davison1, S J Tuft, J K Dart.   

Abstract

We treated 11 episodes of bulbar conjunctival necrosis that occurred in ten patients after therapy for suppurative keratitis with topical fortified aminoglycosides. Chemosis and mucous discharge preceded the development of an area of conjunctival pallor, which stained with fluorescein and was 5 to 10 mm from the corneoscleral limbus. Typical lesions developed in the inferior bulbar conjunctiva after a mean of 4.8 days and 112 mg of gentamicin sulfate (109 drops). The fortified aminoglycoside was the only agent common to all cases. The conjunctival defects healed completely between five and 13 days after treatment was modified to reduce or eliminate aminoglycoside exposure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2039036     DOI: 10.1016/s0002-9394(14)76771-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

1.  In vitro antibiotic resistance in bacterial keratitis in London.

Authors:  S J Tuft; M Matheson
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

2.  Overview: Initial antimicrobial therapy for microbial keratitis.

Authors:  M Daniell
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

3.  The role of preservatives in the conjunctival toxicity of subconjunctival gentamicin injection.

Authors:  M Pande; F Ghanchi
Journal:  Br J Ophthalmol       Date:  1992-04       Impact factor: 4.638

4.  Strategies for the management of microbial keratitis.

Authors:  B D Allan; J K Dart
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

Review 5.  Potential new fluoroquinolone treatments for suspected bacterial keratitis.

Authors:  Rose Herbert; Mary Caddick; Tobi Somerville; Keri McLean; Shakeel Herwitker; Timothy Neal; Gabriela Czanner; Stephen Tuft; Stephen B Kaye
Journal:  BMJ Open Ophthalmol       Date:  2022-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.